Generics
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
15 May 2026 - Apotex Inc, a Canada-based global health company, announced on Thursday the commercial launch in Canada of Apo-Semaglutide Injection, a generic equivalent of Ozempic.The product will be ...
Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA
12 May 2026 - Clinical-stage biopharmaceutical company Transpire Bio Inc announced on Monday that its abbreviated new drug application (ANDA) for fluticasone furoate, umeclidinium, and vilanterol inha...
Kaiser Permanente reports study findings showing significant cost savings
7 May 2026 - Health care provider Kaiser Permanente said on Wednesday that it has commissioned Milliman, a global actuarial and professional services consulting firm, to conduct a study comparing Kais...
Apotex receives Health Canada approval for a generic Ozempic equivalent
4 May 2026 - Apotex Inc, a Canada-based global health company, announced on Friday that Health Canada has approved Apo-Semaglutide InjectionTM, a generic equivalent of Ozempic (semaglutide injection)....
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
24 April 2026 - Indian pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA-EQ) and its US subsidiary Cipla USA Inc announced on Thursday that the US Food and Drug Administration (FDA) has giv...
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
17 April 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has obtained Marketing Authorization in Denmark for Palbociclib Newbury tablets, mark...